from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2493/vapB38

LFCtreatmentdescriptionclass of inhibitor

1.006

Amikacinug/mL Amikacintranslation

1.259

Cap5-10ug/mL Capreomycintranslation

2.301

Rox10-50 ug/mL Roxithromycintranslation

0.119

SM2-5 ug/mL Streptomycintranslation

1.138

Tet5-10 ug/mL Tetracyclinetranslation

-0.628

Rif0.2-5ug/mL Rifampicintranscription

-0.390

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.662

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.972

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.731

CPZ10-50 ug/mL Chlorpromazinerespiration

1.005

Clofazimine10-13 ug/mL Clofaziminerespiration

0.626

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.406

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.509

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.572

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.783

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.579

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.925

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.108

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.407

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.656

KCN5-20 ug/mL Potassium cyaniderespiration

0.590

NaN30.2-2 mM Sodium aziderespiration

0.626

Nigericin50 uM Nigericinrespiration

0.273

TRC10-150 ug/mL Triclosanrespiration

1.091

TRZ10-25 ug/mL Thioridazinerespiration

-0.755

Valinomycin0.5-10 uM Valinomycinrespiration

0.819

ZnSO42 mM ZnSO4respiration

0.389

menadione6-10 ug/mL Menadionerespiration

-0.547

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.027

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.100

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.358

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.437

NRP_1Non-replicating persistence stage 1dosRassociated

0.062

Amp0.2mg/mL AmpicillincellWall

0.391

Cephalexin20-100 ug/mL CephalexincellWall

0.377

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.626

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.030

EMB10-20 ug/mL EthambutolcellWall

0.571

Eta12-40 ug/mL EthionamidecellWall

0.723

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.069

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.134

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.024

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.317

BZA0.12 mg/mL BenzamidearomaticAmides

-0.736

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.516

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.931

H2O24 mM hydrogen peroxideDNAdamaging

-0.112

Levo10 ug/mL LevofloxacinDNAdamaging

-1.408

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.062

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.292

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.764

UVUV-irradiationDNAdamaging

-0.052

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.281

Antimycin12.5-50 ug/mL Antimycin A?

0.080

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.004

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.273

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.340

PA8240.2-2 ug/mL PA-824?

-0.038

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.522

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.172

Verapamil50 uM Verapamil?

0.224

mercaptoethanol2 mM 2-Mercaptoethanol?

0.280

methoxatin10-20 ug/mL Methoxatin?